Stay updated on APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-14T01:13:04.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy or safety assessment of multiple IVT injections of APL-2 in subjects with Geographic Atrophy (GA) secondary to Age-Related Macular Degeneration (AMD) in a Phase III clinical trial.
    Difference
    0.1%
    Check dated 2024-06-06T16:03:54.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns Medical and healthcare-related publications and documentation.
    Difference
    28%
    Check dated 2024-05-22T08:41:45.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-05-01T14:18:16.000Z thumbnail image

Stay in the know with updates to APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial page.